AMD Centre, Department of Ophthalmology & Visual Sciences, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Invest Ophthalmol Vis Sci. 2011 Jul 11;52(8):5144-52. doi: 10.1167/iovs.10-7047.
Recent studies indicate that ethyl pyruvate (EP) exerts anti-inflammatory properties; however, the effect of EP on ocular inflammation is not known. The efficacy of EP in endotoxin-induced uveitis (EIU) in rats was investigated.
EIU in Lewis rats was developed by the subcutaneous injection of lipopolysaccharide (LPS; 150 μg). EP (30 mg/kg body weight) or its carrier was injected intraperitoneally 1 hour before or 2 hours after lipopolysaccharide injection. Animals were killed after 3 and 24 hours followed by enucleation of eyes and collection of the aqueous humor (AqH). The number of infiltrating cells and levels of proteins in the AqH were determined. The rat cytokine/chemokine multiplex method was used to determine level of cytokines and chemokines in the AqH. TNF-α and phospho-nuclear factor kappa B (NF-κB) expression in ocular tissues were determined immunohistochemically. Human primary nonpigmented ciliary epithelial cells (HNPECs) were used to determine the in vitro efficacy of EP on lipopolysaccharide-induced inflammatory response.
Compared to controls, AqH from the EIU rat eyes had a significantly higher number of infiltrating cells, total protein, and inflammatory cytokines/chemokines, and the treatment of EP prevented EIU-induced increases. In addition, EP also prevented the expression of TNF-α and activation of NF-κB in the ciliary bodies and retina of the eye. Moreover, in HNPECs, EP inhibited lipopolysaccharide-induced activation of NF-κB and expression of Cox-2, inducible nitric oxide synthase, and TNF-α.
Our results indicate that EP prevents ocular inflammation in EIU, suggesting that the supplementation of EP could be a novel approach for the treatment of ocular inflammation, specifically uveitis.
最近的研究表明,丙酮酸乙酯(EP)具有抗炎作用;然而,EP 对眼部炎症的影响尚不清楚。本研究旨在探讨 EP 对脂多糖(LPS)诱导的大鼠葡萄膜炎(EIU)的疗效。
通过皮下注射 LPS(150μg)建立 EIU 大鼠模型。EP(30mg/kg 体重)或其载体在 LPS 注射前 1 小时或后 2 小时腹腔内注射。在 3 小时和 24 小时后处死动物,眼球摘出并收集房水(AqH)。检测房水中浸润细胞的数量和蛋白水平。采用大鼠细胞因子/趋化因子多重检测方法检测房水中细胞因子和趋化因子的水平。免疫组化法检测眼组织中 TNF-α和磷酸化核因子 kappa B(NF-κB)的表达。采用人原发性非色素睫状上皮细胞(HNPECs)检测 EP 对 LPS 诱导的炎症反应的体外疗效。
与对照组相比,EIU 大鼠眼房水中的浸润细胞、总蛋白和炎症细胞因子/趋化因子显著增加,EP 治疗可预防 EIU 诱导的增加。此外,EP 还可预防睫状体和视网膜中 TNF-α的表达和 NF-κB 的激活。此外,在 HNPECs 中,EP 抑制 LPS 诱导的 NF-κB 激活和 Cox-2、诱导型一氧化氮合酶和 TNF-α的表达。
我们的研究结果表明,EP 可预防 EIU 中的眼部炎症,提示 EP 的补充可能是治疗眼部炎症,特别是葡萄膜炎的一种新方法。